Aranthan S. Jones II - 15 Sep 2021 Form 4 Insider Report for Vanda Pharmaceuticals Inc. (VNDA)

Reporting relationship: Chief Corp. Affairs Officer
Issuer ticker: VNDA
Reported as of: 15 Sep 2021
Net transaction value: -$136,144
SEC form: 4
Accepted by SEC: 17 Sep 2021, 08:52:04 UTC
Prior SEC filing: 27 Jul 2021
Source filing: View source filing
Reporting owner signature: /s/ Aranthan S. Jones II

Key filing fact

Aranthan S. Jones II filed Form 4 for Vanda Pharmaceuticals Inc. (VNDA) on 17 Sep 2021.

Key facts

This page summarizes Aranthan S. Jones II's Form 4 filing for Vanda Pharmaceuticals Inc. (VNDA).
5 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 17 Sep 2021, 08:52.

Change

Previous filing in this sequence was filed on 27 Jul 2021.
Current net transaction value: -$136,144.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VNDA transaction

Common Stock

Options Exercise

Transaction value: $52,479
Shares: +4,277
Change %: +4.9%
Price: $12.27
Shares after: 90,962
Date: 15 Sep 2021
Ownership: Direct

VNDA transaction

Common Stock

Options Exercise

Transaction value: $88,771
Shares: +7,842
Change %: +8.6%
Price: $11.32
Shares after: 98,804
Date: 15 Sep 2021
Ownership: Direct

VNDA transaction

Common Stock

Sale

Transaction value: $277,394
Shares: -16,824
Change %: -17%
Price: $16.49
Shares after: 81,980
Date: 15 Sep 2021
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VNDA transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -4,277
Change %: -11%
Price: $0.000000
Shares after: 33,224
Date: 15 Sep 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,277
Exercise price: $12.27
Footnotes: F3

VNDA transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -7,842
Change %: -14%
Price: $0.000000
Shares after: 47,158
Date: 15 Sep 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,842
Exercise price: $11.32
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

A portion of the shares was sold to satisfy the exercise price and tax obligations relating to the acquisition of the shares in connection with the stock option exercise.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.40 to $16.605, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Footnote F3

The option vested with respect to 25% of the underlying shares on July 25, 2020, with the remaining 75% of the shares vesting in 36 equal monthly installments beginning August 25, 2020, provided the Reporting Person remains continuously employed by the Issuer through each monthly vesting date.

Footnote F4

The option vested with respect to 25% of the underlying shares on February 26, 2021, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person remains continuously employed by the Issuer through the applicable vesting date.